lives of patients sunovion science revolves around our patients . rethinking the way medicines are engineered . with a specialized focus on two treatment areas . central nervous system cns disorders can affect people at almost any stage of life . this is why there s a real and urgent need for more treatment options . see what we re working on . more and more americans are living with respiratory diseases among them asthma allergies and chronic obstructive pulmonary disease copd . find out what we re doing to help . what s new at sunovion sunovion announces fda filing acceptance of new drug application for sun 101 eflow for the treatment of patients with chronic obstructive pulmonary disease copd sunovion announces results from pivotal study evaluating novel drug candidate dasotraline in children with adhd sunovion to present data on latuda lurasidone at the 29th european college of neuropsychopharmacology ecnp congress sunovion pharmaceuticals to acquire cynapsus therapeutics view the latuda lurasidone hcl tablets press releases see our pipeline see our marketed & pipeline products for cns disorders see our marketed & pipeline products for respiratory diseases meet our leaders work at sunovion sunovion in the community our employee volunteer program sunovion hands on supports communities in need all over the country . our patients come first it isn t innovative if it doesn t get results no one approach provides all the answers we can do more good by specializing healthy living promotes healthy lives our pipeline is our future . and our patients . next in line are promising and potentially important treatments for a number of cns and respiratory disorders . site map terms of use privacy policy and cookie notice medical disclaimer about sumitomo dainippon pharma sunovion and are registered trademarks of sumitomo dainippon pharma co. ltd. sunovion pharmaceuticals inc. is a u.s. subsidiary of sumitomo dainippon pharma co. ltd. lunesta xopenex hfa and brovana are registered trademarks of sunovion pharmaceuticals inc. alvesco omnaris and zetonna are registered trademarks of takeda gmbh used under license . aptiom is used under license from . latuda is a registered trademark of sumitomo dainippon pharma co. ltd. 2016 sunovion pharmaceuticals inc. all rights reserved .